Women's Health Playbook Strategy Platform
Commission a defendable, board-ready business case & intelligence report tailored directly to your organization's current state, existing assets, core strengths, and strategic goals. Built on our multi-agent AI research pipeline and 100% human-in-the-loop—personally synthesized, fact-checked, and strategically edited by Anastasiya Markvarde. Delivered in 72 hours.
Get deep, verified domain intelligence at ~0.5% of traditional consulting retainers. We combine multi-agent AI data gathering with 100% human-in-the-loop expert synthesis—delivered in 72 hours by a recognized women's health leader instead of a generalist junior associate.
From strategic question to execution roadmap — instantly
Defendable Business Case
Build an audit-ready strategic rationale, financial thesis, and biological sex-difference business case tailored to your organization. Pre-packaged for presentation to leadership, boards, and investment committees.
Ecosystem & Dealflow Sourcing
Cross-reference active startups, digital biomarkers, and clinical platforms operating in your target space. Map capital flows, VC investor moves, and partnering white space before competitors enter.
Board-Ready Deliverable
A structured 10-page report covering market trends, regulatory directives, capital flow maps, breakthrough innovations, and a phased execution roadmap—backed by a 1-on-1 debrief call with Anastasiya.
⚙️ Step 1: Configure Your Strategy & Generate Free Preview
Select your strategic parameters below to instantly generate a tailored executive preview on this page.
72-Hour Delivery
Rapid executive turn-around. Multi-agent research pipeline compiles verified signals, followed by direct editorial review.
100% Human-in-the-Loop
No raw AI dumps. Every single report is personally curated, fact-checked, and strategically edited by Anastasiya Markvarde (author of Women's Health Digest, health innovation strategist).
45-Min Consultation
Includes a 1-on-1 strategic debrief call to review findings, answer questions, and discuss market entry execution.